Injective Price Soars on ETF Staking Plans and Phantom Integration

Injective's price surged over 17% as the broader crypto market moved higher, thanks to fresh institutional and ecosystem developments. The proposed Injective ETF from 21Shares has filed an updated S-1 document outlining a potential staking allocation of 40%, 60% of the fund's $INJ holdings.

The ETF filing update introduces a staking strategy for the proposed Injective investment product, with the aim to stake between 40% and 60% of its $INJ holdings. The allocation will be adjustable based on liquidity requirements.

Separately, Injective has integrated with Phantom, enabling users to hold, trade, borrow, and exchange tokens through the wallet's application and web extension.